LSDI Stock Price, Lucy Scientific Discovery . Quote, Chart

Market Summary

USD0.810.00

Delayedas of 03 May 2024, 10:29 am

0.00%

LSDI Stock Price

View Fullscreen

LSDI RSI Chart

LSDI Valuation

Market Cap

14.3M

Price/Earnings (Trailing)

-1.26

Price/Sales (Trailing)

650.97

Price/Free Cashflow

-2.36

LSDI Price/Sales (Trailing)

LSDI Profitability

Operating Margin

36.15%

Return on Equity

-13.9K%

Return on Assets

-263.6%

Free Cashflow Yield

-42.39%

LSDI Fundamentals

LSDI Revenue

LSDI Earnings

Earnings (TTM)

-11.3M

Earnings Growth (Yr)

-180.52%

Earnings Growth (Qtr)

-31.1%

Breaking Down LSDI Revenue

52 Week Range

0.82

(Low)(High)

Last 7 days

-6.9%

Last 30 days

-32.5%

Last 90 days

237.5%

How does LSDI drawdown profile look like?

LSDI Financial Health

Current Ratio

0.38

LSDI Investor Care

Shares Dilution (1Y)

68.97%

Diluted EPS (TTM)

-0.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	0	7.0K	0	0
2022	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold LSDI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Apr 16, 2024	Sageworth Trust Co	sold off	-100	-2,924	-	-%
Feb 14, 2024	CITADEL ADVISORS LLC	added	153	707	10,824	-%
Feb 14, 2024	K2 PRINCIPAL FUND, L.P.	unchanged	-	-85,000	65,000	0.01%
Feb 14, 2024	Walleye Capital LLC	sold off	-100	-117,979	-	-%
Feb 13, 2024	RENAISSANCE TECHNOLOGIES LLC	new	-	17,000	17,000	-%
Feb 13, 2024	AdvisorShares Investments LLC	added	89.33	-56,354	222,780	0.05%
Feb 12, 2024	JPMORGAN CHASE & CO	new	-	1,510	1,510	-%
Feb 09, 2024	HRT FINANCIAL LP	new	-	4,000	4,000	-%

Are Funds Buying or Selling LSDI?

Are funds buying LSDI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LSDI

No. of Funds

Recent SEC filings of Lucy Scientific Discovery Inc.

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	8-K	Current Report
Mar 12, 2024	8-K	Current Report
Mar 01, 2024	424B3	Prospectus Filed
Feb 27, 2024	8-K	Current Report
Feb 27, 2024	EFFECT	EFFECT
Feb 26, 2024	CORRESP	CORRESP
Feb 23, 2024	8-K	Current Report
Feb 22, 2024	S-1/A	Initial Public Offering
Feb 13, 2024	10-Q	Quarterly Report
Feb 06, 2024	S-1/A	Initial Public Offering

Peers (Alternatives to Lucy Scientific Discovery Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	360.8B	85.6B	-4.95%	-7.94%	9.38	4.21	5.68%	202.39%
MRK	324.7B	60.1B	-1.63%	8.46%	889.69	5.4	1.40%	-97.49%
PFE	156.4B	46.5B	0.51%	-27.98%	-112.61	3.36	42.59%	-114.62%
AMGN	149.2B	28.2B	0.79%	21.40%	22.21	5.29	7.09%	2.52%
GILD	81.4B	27.1B	-9.38%	-17.77%	14.37	3	-0.60%	23.36%
TEVA	15.7B	15.8B	1.44%	59.77%	-27.34	0.99	6.17%	76.47%
MID-CAP
PRGO	4.5B	4.7B	5.59%	-11.79%	-352.77	0.96	4.58%	90.97%
ALKS	4.0B	1.7B	-10.87%	-16.72%	9.29	2.34	54.01%	364.56%
BHC	3.0B	9.0B	-20.59%	9.46%	-6.52	0.33	10.01%	-27.45%
AMPH	2.1B	644.4M	0.80%	17.68%	14.92	3.18	29.14%	50.51%
SMALL-CAP
TLRY	1.6B	743.2M	-16.18%	-15.48%	-4.44	2.1	24.65%	80.36%
TXMD	21.8M	1.3M	-16.00%	-50.65%	-2.12	16.74	-98.14%	-109.18%
ACRX	17.1M	-	2.02%	57.81%	-0.93	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	48.15%	-93.36%	-0.19	0.14	80.00%	43.08%
ACOR	1.1M	117.6M	-94.70%	-92.62%	0	0.01	-0.79%	-283.60%

Lucy Scientific Discovery Inc. News

Latest updates

Lucy Scientific Discovery Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)				(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2022Q4
Revenue	-	10.00	-	-	-
Gross Profit	-	6.00	-	-	-
Operating Expenses	-46.0%	868	1,607	2,315	182
S&GA Expenses	-42.5%	868	1,510	2,236	182
Interest Expenses	-67.1%	128	391	402	485
Net Income	-31.1%	-2,619	-1,998	-2,577	-933
Net Income Margin	100.0%	-	-1.36	-1.28	-
Free Cashflow	74.3%	-330	-1,288	-1,860	-124

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet						(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q2
Assets	-31.6%	4,287	6,266	8,779	9,402	4,777	4,632
Current Assets	-15.8%	1,338	1,589	3,822	5,803	1,466	1,899
Cash Equivalents	-11.2%	211	238	1,674	3,426	26.00	53.00
Net PPE	-100.0%	-	668	765	844	844	844
Liabilities	18.0%	4,206	3,564	4,100	3,445	11,560	9,409
Current Liabilities	56.6%	3,487	2,226	2,710	2,070	8,767	5,810
Shareholder's Equity	-97.0%	81.00	2,702	4,679	5,957	-6,783	-4,777
Retained Earnings	-5.6%	-49,033	-46,413	-44,415	-41,838	-37,732	-35,427
Shares Outstanding	0%	17,646	17,646	17,463	16,341	10,444	10,444

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)									(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Cashflow From Operations	74.3%	-330	-1,288	-1,860	-2,579	420	-246	-	-	-
Cashflow From Investing	100.0%	-	-123	-	-300	-	34.00	-	-	-
Cashflow From Financing	-	-	-	1.00	5,880	136	175	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LSDI Income Statement

2023-12-31

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net product sales	$ 9,684		$ 9,684
Cost of sales	3,868		3,868
Gross profit	5,816		5,816
Operating expenses
Selling, general and administrative expense	868,325	182,043	2,254,798	810,675
Total expenses	868,325	182,043	2,254,798	810,675
Non-operating expense (income)
Interest expense	128,471	485,278	519,075	1,028,499
Loss on convertible note issuance (including $151,866 with a related party for the three and six months ended December 31, 2023)	508,599		508,599
Change in commitment to issue common shares (including $19,831 with a related party for the three and six months ended December 31, 2023)	(59,493)		(59,493)
Change in fair value of conversion feature (including $46,479 with a related party for the three and six months ended December 31, 2023)	(139,437)		(139,437)
Change in fair value of default penalty (including $1,033 with a related party for the three and six months ended December 31, 2023)	3,099		3,099
Other income	(6)	(5)	(17)	(44)
Total non-operating expense (income)	441,233	485,273	831,826	1,028,455
Income tax expense for continuing operations
Net loss from continuing operations	(1,303,742)	(667,316)	(3,080,808)	(1,839,130)
Loss from discontinued operations	(1,315,785)	(266,491)	(1,536,769)	(466,418)
Income tax expense for discontinued operations
Net loss from discontinued operations	(1,315,785)	(266,491)	(1,536,769)	(466,418)
Net loss	(2,619,527)	(933,807)	(4,617,577)	(2,305,548)
Foreign exchange translation adjustment, net of tax of $nil	(1,182)	(101,117)	(78,577)	299,663
Comprehensive loss	$ (2,620,709)	$ (1,034,924)	$ (4,696,154)	$ (2,005,885)
Net loss per common share
Net loss from continuing operations (in Dollars per share)	$ (0.07)	$ (0.06)	$ (0.17)	$ (0.18)
Net loss from discontinued operations (in Dollars per share)	(0.07)	(0.03)	(0.09)	(0.04)
Net loss (in Dollars per share)	$ (0.14)	$ (0.09)	$ (0.26)	$ (0.22)
Weighted average number of common shares outstanding
Basic (in Shares)	17,646,296	10,443,560	17,613,801	10,443,560

LSDI Balance Sheet

2023-12-31

Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets
Cash	$ 211,120	$ 1,673,874
Prepaid expenses, current	1,118,025	1,170,021
Accounts receivable	642	7,048
Other assets – GST receivable	8,338	62,649
Other receivable		336,706
Deferred financing costs		523,041
Assets of discontinued operations, current		49,159
Total current assets	1,338,125	3,822,498
Non-current assets
Prepaid expenses, noncurrent	1,503,371	1,663,333
Intangible assets	1,445,552	1,484,250
Assets of discontinued operations, noncurrent		1,808,565
TOTAL ASSETS	4,287,048	8,778,646
Current liabilities
Accounts payable and accrued liabilities	1,384,412	1,291,063
Notes payable	60,487	60,423
Convertible notes (including $3,019 due to a related party as of December 31, 2023)	9,056
Commitment to issue common shares (including $109,714 due to a related party as of December 31, 2023)	329,143
Conversion feature (including $222,507 due to a related party as of December 31, 2023)	667,521
Default penalty (including $23,369 due to a related party as of December 31, 2023)	70,107
Liabilities of discontinued operations, current	357,557	338,819
Total current liabilities	3,486,523	2,710,199
Non-current liabilities
Liabilities of discontinued operations, noncurrent	719,367	1,389,558
TOTAL LIABILITIES	4,205,890	4,099,757
STOCKHOLDERS’ EQUITY (DEFICIT)
Common stock, no par value; unlimited shares authorized; 17,646,296 and 17,462,963 shares issued and outstanding as at December 31, 2023 and June 30, 2023, respectively	49,032,701	48,934,278
Accumulated deficit	(49,033,375)	(44,415,798)
Accumulated other comprehensive income	81,832	160,409
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)	81,158	4,678,889
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	4,287,048	8,778,646
Related Party
Current liabilities
Due to related parties	$ 608,240	$ 1,019,894

About Lucy Scientific Discovery Inc.

Lucy Scientific Discovery Inc. engages in the research, development, manufacture, and sale of psychedelic products. It offers biological raw materials, active pharmaceutical ingredients, and finished biopharmaceutical products. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. The company was incorporated in 2017 and is headquartered in Victoria, Canada.

0

CEO	Mr. Richard D. Nanula
WEBSITE	lucyscientific.com
INDUSTRY	Pharmaceuticals

Lucy Scientific Discovery Inc. Frequently Asked Questions

What is the ticker symbol for Lucy Scientific Discovery Inc.? What does LSDI stand for in stocks?

LSDI is the stock ticker symbol of Lucy Scientific Discovery Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lucy Scientific Discovery Inc. (LSDI)?

As of Thu May 02 2024, market cap of Lucy Scientific Discovery Inc. is 14.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LSDI stock?

You can check LSDI's fair value in chart for subscribers.

What is the fair value of LSDI stock?

You can check LSDI's fair value in chart for subscribers. The fair value of Lucy Scientific Discovery Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lucy Scientific Discovery Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LSDI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lucy Scientific Discovery Inc. a good stock to buy?

The fair value guage provides a quick view whether LSDI is over valued or under valued. Whether Lucy Scientific Discovery Inc. is cheap or expensive depends on the assumptions which impact Lucy Scientific Discovery Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LSDI.

What is Lucy Scientific Discovery Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 02 2024, LSDI's PE ratio (Price to Earnings) is -1.26 and Price to Sales (PS) ratio is 650.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LSDI PE ratio will change depending on the future growth rate expectations of investors.